Stocks making the biggest moves midday: AeroVironment, Abivax, Astera Labs, Watts Water Technologies & more
Here are the companies making headlines in midday trading.
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
The Trump administration has expanded access to nicotine products despite concerns from public health critics about youth use and addiction.
Nike results top estimates even as China sales drop 12%; retailer expects $986 million tariff refund
Nike was expected to report another quarter of declining sales as the sneaker giant struggles to regain strength under its turnaround strategy.
Here are Deutsche Bank’s top investment ideas for the third quarter of 2026
The third quarter is about to kick off after strong first half for stocks, with Deutsche Bank seeing strong performances ahead for a select group of names.
AWS puts $1 billion into new AI unit to embed engineers with customers, joining growing wave
AWS FDEs will look to leave behind self-sufficient teams with new AI solutions and capabilities in a matter of weeks, the company said.
Supreme Court upholds birthright citizenship, blocks Trump order
President Donald Trump attended oral arguments in the case, underscoring his staunch opposition to granting automatic citizenship to many immigrants’ babies.
Supreme Court strikes down limits on political parties’ campaign spending, in win for GOP
President Donald Trump took a victory lap after the ruling, writing on Truth Social that it was “A BIG WIN FOR REPUBLICANS.”
AeroVironment skyrockets 19% as dronemaker capitalizes on defense spending surge
AeroVironment is benefiting from U.S. plans to modernize the U.S. military and secure space.
Mike Santoli: A great first half, but some erratic behavior raises doubts about the rally’s integrity
For the past few weeks, the stock market has been attempting to rediscover some equilibrium after a stretch of semiconductor dominance, a breakdown in Mag7 stalwarts and more recently rotation toward the broader roster of non-tech stocks.
Small-cap stocks enjoy their best first half in 35 years. Here’s what’s driving it
The advance marks a sharp turnaround after years of underperformance versus large-cap peers.
